We do the sorting. You do the medicine.
Medical and endocrine disease · Core02 / 30

Type 2 diabetes on a GLP-1 agonist and SGLT2 inhibitor for laparoscopic colectomy58-year-old man, 96 kg, for elective laparoscopic right hemicolectomy on an enhanced-recovery pathway

Diabetes: GLP-1 aspiration risk, SGLT2 ketoacidosis and autonomic neuropathy

From memory: the diagnosis and the notes are hidden. Answer each question aloud, then press Show.

Know this first

  • GLP-1 agonists slow gastric emptying, so aspiration risk persists despite a standard fast.
  • SGLT2 inhibitors are stopped 3–4 days before surgery to prevent euglycaemic ketoacidosis.
  • Resting tachycardia and lost heart-rate variability are early signs of autonomic neuropathy.
  • In autonomic failure, a direct-acting vasopressor is preferred over an indirect one.

The patient

58-year-old man, 96 kg, for elective laparoscopic right hemicolectomy on an enhanced-recovery pathway. Type 2 diabetes for 15 years: HbA1c 9.4%, nephropathy (eGFR 48), dizzy on standing, full after small meals. Drugs: insulin glargine, weekly semaglutide (last dose 3 days ago), empagliflozin, metformin. Vitals: BP 150/88 lying, 118/76 standing; HR 98 and fixed; SpO2 96% on air; glucose 214 mg/dL.

The examiner asks

Answer aloud, then press Show.

  1. Consider

    What are your concerns?

    Show the answerHide the answer
    • A 58-year-old with poorly controlled type 2 diabetes and organ damage, for elective laparoscopic colectomy. Patient
    • His kidneys, nerves and likely silent coronary disease all shape this anaesthetic. Disease
    • Semaglutide delays his gastric emptying; he may aspirate even after a normal fast.
    • Empagliflozin plus fasting can tip him into ketoacidosis with a near-normal glucose.
    • His postural drop and fixed heart rate point to autonomic neuropathy: arrhythmias and hypotension under anaesthesia.
  2. Prepare

    How do you prepare him for the day?

    Show the answerHide the answer
    • HbA1c 9.4% reflects about three months of poor control, so I review heart, kidneys and nerves. (Disease)
    • Empagliflozin stops 3–4 days before surgery.
    • On the day I check his ketones and anion gap, whatever his glucose reads.
    • Glargine cut by 20%; metformin and other oral agents held that morning.
    • His early fullness raises risk: semaglutide held a week ahead if we agree to hold.
    • Because of his symptoms, a liquid diet for 24 hours beforehand.
  3. Plan

    How do you run his anaesthetic and his glucose?

    Show the answerHide the answer
    • Gastric ultrasound on the day if I'm unsure his stomach is empty. Airway
    • Solids seen, or still unsure: a rapid sequence, using rocuronium 1.2 mg/kg.
    • Long fast and long case: variable-rate insulin, with dextrose and potassium running alongside. Disease
    • Hourly glucose, with 140–180 mg/dL as his target.
    • Dexamethasone for PONV will raise his glucose because his control is poor; I treat to target.
    • Oral agents restart once he is eating a normal diet. After surgery
  4. Crisis

    At induction, after propofol and before the relaxant works, gastric fluid wells up in his pharynx. SpO2 97%. What do you do?

    Show the answerHide the answer
    • Regurgitation at induction, in a man on a GLP-1 agonist with gastroparesis. Crisis
    • Tilt him head-down and suction his pharynx at once.
    • Intubate with a cuffed tube, then suction down it on 100% oxygen. Airway
    • Bronchoscopy if particles may have gone down; no saline washout, which spreads the aspirate. Crisis
    • If his oxygenation holds, I discuss with the surgeon whether to proceed. Surgery
    • A quarter of patients who aspirate develop significant lung problems, so he's watched closely afterwards. After surgery
  5. Crisis

    Five minutes after intubation his BP is 68/40, HR 98. Two ephedrine boluses have done nothing. What now?

    Show the answerHide the answer
    • Refractory hypotension with autonomic neuropathy; indirect agents work poorly in him. (Crisis)
    • Phenylephrine 50–100 mcg, starting small because his alpha receptors may be upregulated.
    • If he stays low, noradrenaline by infusion, 0.05–0.3 mcg/kg/min.
    • Arterial line now, with fluid as needed to protect his diabetic kidneys.
    • I also exclude hypoxia from aspiration, bleeding, and anaphylaxis to the relaxant.

Fatal mistakes

  • Treating a GLP-1 agonist patient with early fullness as having an empty stomach.
  • Running an insulin infusion without dextrose, potassium or hourly glucose.
  • Continuing his SGLT2 inhibitor into a prolonged fast.

Checked against: Miller 10e · Stoelting 8e · Multi-society guidance on GLP-1 receptor agonists before procedures (2024) · Faust

Report a problem with this case

Mark Got it only if you said every point. Again brings the case back tomorrow; Got it brings it back in 3, then 7, 14 and 30 days.

All Medical and endocrine disease casesBack to today